The federal Ryan White HIV/AIDS (Ryan White) Program provides grants to states and other entities to support services for low-income people with HIV. The Department of Health (DOH) receives Ryan White grant funding to operate the Early Intervention Program (EIP). Among other services, the EIP provides payment for certain HIV-related medications.
Purchases of these HIV-related medications generate rebates from pharmaceutical companies, which are deposited into the State General Fund. The DOH requests appropriations authority to spend this rebate revenue on EIP services. The Ryan White program requires expenditure of these rebate revenues on EIP services before federal funding is used.
The non-appropriated Medication for People Living with HIV Rebate Revenue Account (Account) is created in the custody of the State Treasury. The EIP must deposit any receipts from pharmaceutical rebates generated by the purchase of medications, and revenue generated from federal grant funds, for any person enrolled in the EIP into the Account. The expenditures may only be used for services defined in the grant award from the Ryan White grant program, and only the Secretary of Health, or the Secretary's designee, may authorize expenditures from the Account.